SPECIAL NOTICE
99 -- Posting of the DRFP2 Comments for the National Cancer Institute�s (NCI) supporting the NCI Federally Funded Research and Development Center (FFRDC)/Frederick National Laboratory for Cancer Research (FNLCR)
- Notice Date
- 5/13/2022 12:33:33 PM
- Notice Type
- Special Notice
- Contracting Office
- NIH NCI ROCKVILLE MD 20852 USA
- ZIP Code
- 20852
- Solicitation Number
- HHS-NIH-NCI-RFI-MOSB-75N91020R00062-24
- Response Due
- 5/30/2022 1:00:00 PM
- Point of Contact
- Lisa Coleman, Lisa Bielen
- E-Mail Address
-
licoleman@mail.nih.gov, lisa.bielen@nih.gov
(licoleman@mail.nih.gov, lisa.bielen@nih.gov)
- Description
- PURPOSE: THIS IS A SPECIAL NOTICE. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this Special Notice is to provide responses to questions received in response to the second Draft RFPs released on 4 February 2022. Please find the document entitled �DRFP2 QA Final� attached. ADDITIONAL INFORMATION: Additional information concerning the competitive process for the contract will be announced on https://beta.sam.gov/ as well as at the FNLCR Acquisition Portal: https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/. The information posted to Beta SAM takes precedence over information provided elsewhere and serves as the Government�s official government-wide point of entry (GPE). If you have questions, please email the FNLCR Acquisition Team at: FNLCR_ACQinfo@nih.gov �(FNLCR_ACQinfo@nih.gov).
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/8fa5fbf06a394f318347a81c882238b6/view)
- Record
- SN06326520-F 20220515/220513230057 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |